Anne CC Lee is the Levinger Family Professor of Pediatrics at Warren Alpert Medical School of Brown University and Founding Director of the Brown Alliance for Infant and Maternal Health Research (Global AIM). Dr. Lee received her B.S.E. in biomedical engineering at Duke University, M.D. from Harvard Medical School, and M.P.H. at Johns Hopkins Bloomberg School of Public Health. She completed pediatrics residency training at Boston Children’s Hospital/Boston Medical Center, and a postdoctoral research fellowship at the Hopkins International Center for Maternal and Newborn Health.
Dr. Lee’s research focus is on perinatal epidemiology and the design, evaluation, and implementation of interventions to reduce mortality and optimize the health of mothers, newborns, and children globally. She coordinated the Child Health Epidemiology Reference Group Small for Gestational Age-Preterm Birth and Neonatal Morbidity working groups to generate the first global estimates of the burden of fetal growth restriction, neonatal encephalopathy, and childhood impairment related to neonatal conditions. These estimates were included in the UNICEF-World Health Organization “Every Newborn Action Plan,” endorsed by the World Health Assembly. She collaborates with the WHO Department of Maternal, Newborn, Child and Adolescent Health, where she has contributed to the development of guidelines for the management of neonatal sepsis and preterm infants.
Dr. Lee has led innovation in tools and intervention strategies to improve the outcomes of small and vulnerable newborns. She has led large scale randomized controlled trials of multi-sectoral prenatal interventions to prevent preterm birth and low birth weight in Ethiopia and Bangladesh. In partnership with the WHO, she has coordinated initiatives to develop novel, simplified methods of gestational age assessment before and after birth in low-income countries. As a biomedical engineer and mother of two children with severe neonatal hyperbilirubinemia, Dr. Lee invented the Bili-ruler, a non-invasive screening tool used to screen for newborn jaundice in resource-constrained settings where laboratory testing is not available. She has served on committees for the Eunice Kennedy Shriver National Institute of Child Health and Human Development and National Academies of Sciences, Engineering and Medicine.